Navigation Links
Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
Date:9/26/2007

n affiliated company of Schering-Plough Corporation (NYSE: SGP) and in August 2007 sold its marketing rights, with the exception of the US, to EUSA Pharma. Other late stage pharmaceutical products in Innocoll's development pipeline include CollaRx Gentamicin Topical for the treatment and prevention of infected diabetic foot ulcers and Bupivacaine Implant for the management of post-operative pain, both of which are currently in Phase 2 development. For more information, please visit http://www.innocoll.com.


'/>"/>
SOURCE Innocoll, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
2. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
3. XTL Provides Update on Phase I Clinical Trial of XTL-2125
4. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
5. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
6. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
7. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
8. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
9. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
10. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
11. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Mass., Dec. 16 Boston Scientific Corporation (NYSE: ... Board of Directors has elected Nelda Connors as a ... of the Electrical and Metal Products division of Tyco ... Eaton Corporation, holding several positions in operations and general ... in a number of executive and management capacities with ...
(Date:12/16/2009)... Pa., Dec. 16 Siemens ... financing solutions to ... and meet deadlines defined within the HITECH ... Act (ARRA). Featuring zero-percent interest ... organizations to defer up-front payments associated with ...
(Date:12/16/2009)... Dec. 16 BioSpecifics Technologies Corp. (Nasdaq: ... in class collagenase-based products, today announced top-line efficacy ... trial of XIAFLEX(TM) for the treatment of Peyronie,s ... of inelastic collagen on the shaft of the ... sexual intercourse difficult or impossible in advanced cases. ...
Breaking Medicine Technology:Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 2Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 4BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4Traveling With Diabetes The Positive Way 55962 1Traveling With Diabetes The Positive Way 55962 2Traveling With Diabetes The Positive Way 55962 3Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 1Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 2Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 3Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 4Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 5SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 1SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 2SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 3SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 4SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 5SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 6SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 7SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 8SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 9
(Date:12/16/2009)... (Nasdaq: BLUD ), a global leader in providing ... announced that Paul D. Mintz, M.D. has been appointed ... January 1, 2010. ,, Dr. Mintz has been ... than 30 years. He is a tenured Professor of ... of Medicine. He also serves as director of the ...
(Date:12/16/2009)... 16 For wounded U.S. servicemen ... in Washington, D.C., the holidays can be a particularly ... travel home rely more than ever on the healing ... week, calling home just got easier for Walter Reed ... cards, which will provide hundreds of minutes of holiday ...
(Date:12/16/2009)... -- HealthSciences Institute will sponsor a new ... and organizations who serve individuals at risk ... employer, health plan, medical home and other ... free, noncommercial webinars on topics, solutions and ... and care improvement. Each webinar will include ...
(Date:12/16/2009)... a role in reducing inflammation in the lungs , , ... that plays a role in inflammation seems to protect ... adults who smoke. , Researchers also found that adult ... a lower risk of developing chronic obstructive pulmonary disease ... , "The gene seems to be protective of the ...
(Date:12/16/2009)... GAINESVILLE, Fla. University of Florida researchers at work ... the first to predict the spread of the disease ... than 21 million calls to determine how often residents ... region composed of two islands off the coast of ... in recent years. Its government commissioned the study as ...
Breaking Medicine News(10 mins):Health News:Immucor Appoints New Board Director 2Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3
... - CRH Medical Corporation,(CRM:TSX-V) announced today that it ... Chicago. The new Clinic will be located west ... CRH,s overall,patient appointment capacity and expands accessibility to ... the Chicago expansion, Edward Wright CEO of CRH ...
... Oct. 10 Major financial implications are,at stake ... record,the health conditions of patients that are present ... Centers for Medicare and Medicaid,Services (CMS). CMS ... (DRG),assignment, including new methods for identifying patients who ...
... 10 Abbott has been named to,Hispanic Business ... Abbott was recognized as one of the magazine,s ... hiring, promotion, marketing,philanthropy and supplier diversity. "As ... of our,people to provide different ideas, perspectives and ...
... Web Cast Set for 11:00 a.m. EDT, POWAY, ... a leading provider of diagnostic imaging systems and,services to ... before the market opens on Thursday, October 25,2007, financial ... 30, 2007. A conference call is scheduled for ...
... Evaluation of ATIR by Dr. Velardi for ... Mismatched Bone Marrow Transplantation, AMSTERDAM, Netherlands, ... physician initiated European Phase II,clinical study for its lead product ... the successful treatment of,thirteen end stage blood cancer patients with ...
... against identity theft, but what about medical identity theft? ... danger if false entries in medical records lead to ... uses a person,s name and sometimes other parts of ... the person,s knowledge or consent to obtain medical services ...
Other Medicine News:Health News:CRH Medical Corporation opens second clinic in Chicago 2Health News:Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms 2Health News:Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms 3Health News:Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine 2Health News:Digirad Corporation to Release Third Quarter, Nine-Month Financial Results on October 25, 2007 2Health News:Kiadis Pharma Announces ATIR Interim Clinical Results 2Health News:Kiadis Pharma Announces ATIR Interim Clinical Results 3Health News:Medical identity theft: the importance of protecting your health records 2
There are many reasons to choose the CardioGenesis 2000 Holmium:YAG Laser System for TMR in your hospital or medical facility. Among the first is the CardioGenesis commitment to deliver the highest q...
Ultrasensitive TSH EIA Thyroid Function 025-BC-1003...
Total T3 EIA Thyroid Function 025-BC-1005...
... anti-TPO test kit is a solid phase ... It is designed for the quantitative measurement ... in serum or plasma. The microplate is ... controls and patient samples are pipetted into ...
Medicine Products: